Stryker Corporation (SYK)
Healthcare • Medical Devices
StockNYSEUnited StatesUS8636671013
312.39 USD
-2.01% today Updated 12 Nov 2026 21:22
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Stryker Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:22. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
28 Jan 2027
in 76 days · 16:00 · estimate 5.02
Last results
3.52 vs 3.55 estimated
29 Oct 2026 · In line -0.8%
Beat the estimate
9 of 12
1 missed · 2 in line
Average surprise
+1.8%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 28 Jan 2027 16:00 | 5.02 | — | — | Upcoming |
| 29 Oct 2026 16:00 | 3.55 | 3.52 | -0.8% | In line |
| 30 Jul 2026 16:00 | 3.49 | 3.69 | +5.8% | Beat |
| 30 Apr 2026 16:00 | 2.98 | 2.60 | -12.9% | Miss |
| 29 Jan 2026 16:00 | 4.40 | 4.47 | +1.7% | Beat |
| 30 Oct 2025 16:00 | 3.13 | 3.19 | +1.9% | Beat |
| 31 Jul 2025 16:00 | 3.07 | 3.13 | +2.0% | Beat |
| 01 May 2025 16:00 | 2.73 | 2.84 | +4.0% | Beat |
| 28 Jan 2025 16:00 | 3.87 | 4.01 | +3.5% | Beat |
| 29 Oct 2024 16:00 | 2.77 | 2.87 | +3.5% | Beat |
| 30 Jul 2024 16:00 | 2.79 | 2.81 | +0.7% | In line |
| 30 Apr 2024 16:00 | 2.36 | 2.50 | +6.1% | Beat |
| 30 Jan 2024 16:00 | 3.27 | 3.46 | +5.9% | Beat |
| 02 Nov 2023 16:00 | 2.44 | 2.46 | +0.9% | In line |
| 03 Aug 2023 16:00 | 2.38 | 2.54 | +6.8% | Beat |
| 01 May 2023 16:00 | 2.00 | 2.14 | +6.9% | Beat |
| 31 Jan 2023 16:00 | 2.84 | 3.00 | +5.8% | Beat |
| 31 Oct 2022 16:00 | 2.23 | 2.12 | -4.9% | Miss |
| 26 Jul 2022 16:00 | 2.28 | 2.25 | -1.5% | Miss |
| 28 Apr 2022 16:00 | 1.92 | 1.97 | +2.7% | Beat |
| 27 Jan 2022 16:00 | 2.72 | 2.71 | -0.5% | In line |
| 28 Oct 2021 16:00 | 2.28 | 2.20 | -3.6% | Miss |
| 27 Jul 2021 16:00 | 2.13 | 2.25 | +5.9% | Beat |
| 27 Apr 2021 16:00 | 1.98 | 1.93 | -2.8% | Miss |
| 27 Jan 2021 16:00 | 2.55 | 2.81 | +10.2% | Beat |
| 29 Oct 2020 16:00 | 1.43 | 2.14 | +50.0% | Beat |
| 30 Jul 2020 16:00 | 0.57 | 0.64 | +12.3% | Beat |
| 30 Apr 2020 17:00 | 1.74 | 1.84 | +5.7% | Beat |
| 28 Jan 2020 16:00 | 2.46 | 2.49 | +1.4% | Beat |
| 29 Oct 2019 16:00 | 1.90 | 1.91 | +0.4% | In line |
| 25 Jul 2019 16:00 | 1.94 | 1.98 | +2.2% | Beat |
| 23 Apr 2019 16:00 | 1.84 | 1.88 | +2.2% | Beat |
| 29 Jan 2019 16:00 | 2.15 | 2.18 | +1.3% | Beat |
| 25 Oct 2018 16:00 | 1.68 | 1.69 | +0.7% | In line |
| 24 Jul 2018 16:00 | 1.73 | 1.76 | +1.8% | Beat |
| 26 Apr 2018 16:00 | 1.60 | 1.68 | +5.0% | Beat |
| 30 Jan 2018 16:00 | 1.95 | 1.96 | +0.3% | In line |
| 26 Oct 2017 16:00 | 1.50 | 1.52 | +1.6% | Beat |
| 27 Jul 2017 16:00 | 1.51 | 1.53 | +1.4% | Beat |
| 25 Apr 2017 16:00 | 1.43 | 1.48 | +3.4% | Beat |
| 24 Jan 2017 16:00 | 1.76 | 1.78 | +0.9% | In line |
| 27 Oct 2016 16:00 | 1.37 | 1.39 | +1.1% | Beat |
| 21 Jul 2016 16:00 | 1.37 | 1.39 | +1.8% | Beat |
| 20 Apr 2016 16:00 | 1.20 | 1.24 | +3.3% | Beat |
| 26 Jan 2016 16:00 | 1.55 | 1.56 | +0.4% | In line |
| 22 Oct 2015 16:00 | 1.23 | 1.25 | +1.9% | Beat |
| 23 Jul 2015 16:00 | 1.17 | 1.20 | +2.6% | Beat |
| 21 Apr 2015 16:00 | 1.08 | 1.11 | +2.4% | Beat |
| 27 Jan 2015 16:00 | 1.45 | 1.44 | -0.8% | In line |
| 16 Oct 2014 16:00 | 1.14 | 1.15 | +1.2% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 25.1B | +11.2% | 3.2B | 12.9% | 8.40 | +8.2% | 4.3B |
| 2024 | 22.6B | +10.2% | 3B | 13.2% | 7.76 | -5.9% | 3.5B |
| 2023 | 20.5B | +11.1% | 3.2B | 15.4% | 8.25 | +33.7% | 3.1B |
| 2022 | 18.4B | — | 2.4B | 12.8% | 6.17 | — | 2B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 321.42 | 323.61 | 311.81 | 312.39 | -2.01% | 2,365,008 | |
| 11 Nov 2026 | 319.23 | 320.70 | 315.37 | 318.79 | -1.70% | 3,215,300 | |
| 10 Nov 2026 | 324.07 | 324.76 | 317.87 | 324.29 | -0.44% | 2,637,300 | |
| 09 Nov 2026 | 328.88 | 330.33 | 324.66 | 325.73 | -0.04% | 2,551,400 | |
| 06 Nov 2026 | 324.41 | 328.02 | 322.56 | 325.87 | -2.75% | 3,778,600 | |
| 05 Nov 2026 | 342.45 | 349.48 | 329.86 | 335.08 | -1.35% | 4,459,300 | |
| 04 Nov 2026 | 327.94 | 342.65 | 322.00 | 339.65 | +9.37% | 6,488,200 | |
| 03 Nov 2026 | 307.12 | 312.74 | 306.41 | 310.55 | +1.22% | 2,588,300 | |
| 02 Nov 2026 | 294.31 | 307.90 | 293.00 | 306.81 | +5.12% | 3,739,400 | |
| 30 Oct 2026 | 287.97 | 299.17 | 282.18 | 291.86 | -6.38% | 6,437,800 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- A $19 Billion Fund Bought These 3 Stocks (opens in a new tab) TIKR · 12 Nov 2026 16:48
- Is Current Price Of Stryker Stock A Strong Support? (opens in a new tab) Trefis · 10 Nov 2026 16:48
- Ronda E Stryker Executes Sell Order: Offloads $178.92M In Stryker Stock (opens in a new tab) Benzinga · 10 Nov 2026 11:02
- Stryker Corporation Increases Board Size to 12 and Elects James E. Davis (opens in a new tab) Fintel · 10 Nov 2026 03:42
- Stryker announces intention to nominate Jim Davis to board of directors (opens in a new tab) 09 Nov 2026 21:05
- Piper Sandler Maintains Overweight on Stryker, Raises Price Target to $350 (opens in a new tab) Benzinga · 09 Nov 2026 08:29
- Stryker (SYK) Stock May Be 22% Undervalued On Manufacturing Issues (opens in a new tab) Simply Wall St. · 06 Nov 2026 05:14
- Here's How Much $1000 Invested In Stryker 15 Years Ago Would Be Worth Today (opens in a new tab) Benzinga · 05 Nov 2026 12:18
- Stryker Files Prospectus For Offering Mixed Shelf; Terms Undisclosed (opens in a new tab) Benzinga · 04 Nov 2026 18:27
- Zimmer raises sales forecast despite slower knee business (opens in a new tab) MedTech Dive · 04 Nov 2026 17:30
- Are Options Traders Betting on a Big Move in Stryker Stock? (opens in a new tab) Zacks · 04 Nov 2026 14:30
- A Memo To Stryker's Orthopaedics Team About Winning Again (opens in a new tab) Trefis · 03 Nov 2026 12:17
- Truist Securities Reiterates Hold on Stryker, Lowers Price Target to $305 (opens in a new tab) Benzinga · 02 Nov 2026 12:12
- Stifel Maintains Buy on Stryker, Lowers Price Target to $325 (opens in a new tab) Benzinga · 02 Nov 2026 10:54
- SYK Q3 deep dive: Orthopedics softness, margin pressure, and product launches shape outlook (opens in a new tab) StockStory · 01 Nov 2026 02:51
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 318.79 USD
- Market cap
- 118.9B
- Dividend yield
- 1.13%
- 5-year average yield
- 0.99%
- Payout ratio
- 37%
- Last dividend
- 0.8800 USD · 30 Sep 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 30 Sep 2026 | 0.8800 USD |
| 30 Jun 2026 | 0.8800 USD |
| 31 Mar 2026 | 0.8800 USD |
| 31 Dec 2025 | 0.8800 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 4.7 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 24.8 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 13.1 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 5.3 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 3.1 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 33.95× | Weak | 30.56× |
| P/E (forward) | 19.57× | Fair | 14.16× |
| Price / book | 5.17× | Weak | 3.5× |
| Price / sales | 4.61× | Fair | 3.33× |
| EV / EBITDA | 17.78× | Weak | 11.19× |
| Free cash flow yield | 3.1% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 65.7% | Good | 54.9% |
| Operating margin | 24% | Good | 5.8% |
| Net margin | 13.8% | Good | 1.2% |
| Return on equity | 16% | Good | 4.4% |
| Return on assets | 8.4% | Good | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 10.8% | Good | 10.1% |
| EPS growth / year | 10.8% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.66× | Good | 0.4× |
| Net debt / EBITDA | 1.62× | Fair | 1.46× |
| Interest cover | 8.33× | Good | 2.17× |
| Current ratio | 2.18× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 37.5% | Good | 0% |
| Payout of free cash flow | 34.7% | Good | 28.7% |
| Payout of free cash flow (3 years) | 33.4% | Good | — |
| Dividend growth / year | 10.7% | Good | 6.5% |
| Years of rising dividends | 13 | Good | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow SYK and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.